Shenzhen Lifotronic Technology Co., Ltd. (688389.SS)
CNY 15.22
(0.33%)
CNY 15.22
(0.33%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.33 Billion CNY | 28.06% |
| 2022 | 1.82 Billion CNY | 23.47% |
| 2021 | 1.47 Billion CNY | 14.34% |
| 2020 | 1.28 Billion CNY | 9.38% |
| 2019 | 1.17 Billion CNY | 45.21% |
| 2018 | 811.92 Million CNY | 14.29% |
| 2017 | 710.39 Million CNY | 42.79% |
| 2016 | 497.51 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.41 Billion CNY | 2.69% |
| 2024 Q1 | 2.35 Billion CNY | 0.9% |
| 2024 Q3 | 2.82 Billion CNY | 16.87% |
| 2023 Q4 | 2.33 Billion CNY | 10.25% |
| 2023 Q1 | 1.98 Billion CNY | 9.16% |
| 2023 FY | 2.33 Billion CNY | 28.06% |
| 2023 Q2 | 2.04 Billion CNY | 2.91% |
| 2023 Q3 | 2.11 Billion CNY | 3.4% |
| 2022 FY | 1.82 Billion CNY | 23.47% |
| 2022 Q4 | 1.82 Billion CNY | 4.92% |
| 2022 Q3 | 1.73 Billion CNY | 7.65% |
| 2022 Q2 | 1.61 Billion CNY | 6.9% |
| 2022 Q1 | 1.5 Billion CNY | 2.26% |
| 2021 Q1 | 1.32 Billion CNY | 2.84% |
| 2021 Q2 | 1.34 Billion CNY | 1.35% |
| 2021 Q3 | 1.37 Billion CNY | 2.25% |
| 2021 FY | 1.47 Billion CNY | 14.34% |
| 2021 Q4 | 1.47 Billion CNY | 7.29% |
| 2020 Q4 | 1.28 Billion CNY | 6.21% |
| 2020 Q1 | 1.21 Billion CNY | 2.84% |
| 2020 FY | 1.28 Billion CNY | 9.38% |
| 2020 Q2 | 1.2 Billion CNY | -0.23% |
| 2020 Q3 | 1.21 Billion CNY | 0.37% |
| 2019 Q2 | 787.24 Million CNY | 0.0% |
| 2019 FY | 1.17 Billion CNY | 45.21% |
| 2019 Q3 | 792.26 Million CNY | 0.64% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q4 | 1.17 Billion CNY | 48.81% |
| 2018 FY | 811.92 Million CNY | 14.29% |
| 2018 Q4 | 811.92 Million CNY | 0.0% |
| 2017 FY | 710.39 Million CNY | 42.79% |
| 2016 FY | 497.51 Million CNY | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Chison Medical Technologies Co., Ltd. | 1.52 Billion CNY | -53.13% |